The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

The new drug, simply called the Wegovy pill, marks a turning point in the modern weight-loss revolution. Until now, every ...

Novo Nordisk’s US medical lead, Dr Jason Brett, told CNN that the pill is expected to give patients more choices and help ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

Wegovy's new pill has been approved in the US, offering a needle-free option with a lower starting price than injections.

Instead of weekly injections, patients will soon be able to swallow a daily pill to lose weight. Novo Nordisk's pill form of Wegovy is the first to gain Food and Drug Administration approval.

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...